CORC

在结果中检索

CORC

浏览/检索结果: 共364条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Research on Deep Learning Denoising Method in an Ultra-Fast All-Optical Solid-State Framing Camera 会议论文
Dublin, Ireland, 2021-07-19
作者:  Zhou, Jian;  Wang, Zhuping;  Wang, Tao;  Yang, Qing;  Wen, Keyao
收藏  |  浏览/下载：28/0  |  提交时间：2021/09/03
GaAs material photorefractive response time measurement based on spectral probe 会议论文
Xian, PEOPLES R CHINA, 2020-10-15
作者:  Yang, Qing;  Yin, Fei;  Wang, Tao;  Gao, Guilong;  He, Kai
收藏  |  浏览/下载：30/0  |  提交时间：2021/07/23
A Residual Lifetime Prediction Method of Aging Polyethylene Gas Pipes in Service 会议论文
San Antonio, TX, United states, July 14, 2019 - July 19, 2019
作者:  Wang, Yang;  Lan, Hui-Qing;  Zhang, Hao
收藏  |  浏览/下载：6/0  |  提交时间：2021/04/12
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：140/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
THREE-DIMENSIONAL PRINTING OF MITRAL VALVE PROLAPSE USING ECHOCARDIOGRAPHIC DATA 会议论文
作者:  Zhou, Qing;  Yang, Yuan-Ting;  Song, Hong-Ning;  Chen, Sikai;  Wang, Hao
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
THREE-DIMENSIONAL PRINTING OF MITRAL VALVE PROLAPSE USING ECHOCARDIOGRAPHIC DATA 会议论文
作者:  Zhou, Qing;  Yang, Yuan-Ting;  Song, Hong-Ning;  Chen, Sikai;  Wang, Hao
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace